The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Intravenous Lidocaine on the Neuropathic Pain of Failed Back Surgery Syndrome

  • Park, Chan-Hong (Department Anesthesiology and Pain Medicine, Daegu Wooridul Spine Hospital) ;
  • Jung, Sug-Hyun (Department Anesthesiology and Pain Medicine, Daegu Wooridul Spine Hospital) ;
  • Han, Chang-Gyu (Department Anesthesiology and Pain Medicine, Daegu Wooridul Spine Hospital)
  • Received : 2012.02.01
  • Accepted : 2012.03.13
  • Published : 2012.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: An intravenous infusion of lidocaine has been used on numerous occasions to produce analgesia in neuropathic pain. In the cases of failed back surgery syndrom, the pain generated as result of abnormal impulse from the dorsal root ganglion and spinal cord, for instance as a result of nerve injury may be particularly sensitive to lidocaine. The aim of the present study was to identify the effects of IV lidocaine on neuropathic pain items of FBSS. Methods: The study was a randomized, prospective, double-blinded, crossover study involving eighteen patients with failed back surgery syndrome. The treatments were: 0.9% normal saline, lidocaine 1 mg/kg in 500 ml normal saline, and lidocaine 5 mg/kg in 500 ml normal saline over 60 minutes. The patients underwent infusions on three different appointments, at least two weeks apart. Thus all patients received all 3 treatments. Pain measurement was taken by visual analogue scale (VAS), and neuropathic pain questionnaire. Results: Both lidocaine (1 mg/kg, 5 mg/kg) and placebo significantly reduced the intense, sharp, hot, dull, cold, sensitivity, itchy, unpleasant, deep and superficial of pain. The amount of change was not significantly different among either of the lidocaine and placebo, or among the lidocaine treatments themselves, for any of the pain responses, except sharp, dull, cold, unpleasant, and deep pain. And VAS was decreased during infusion in all 3 group and there were no difference among groups. Conclusions: This study shows that 1 mg/kg, or 5 mg/kg of IV lidocaine, and palcebo was effective in patients with neuropathic pain attributable to FBSS, but effect of licoaine did not differ from placebo saline.

Keywords

References

  1. Onesti ST. Failed back syndrome. Neurologist 2004; 10: 259-64. https://doi.org/10.1097/01.nrl.0000138733.09406.39
  2. Waguespack A, Schofferman J, Slosar P, Reynolds J. Etiology of long-term failures of lumbar spine surgery. Pain Med 2002; 3: 18-22. https://doi.org/10.1046/j.1526-4637.2002.02007.x
  3. Burton CV, Kirkaldy-Willis WH, Yong-Hing K, Heithoff KB. Causes of failure of surgery on the lumbar spine. Clin Orthop Relat Res 1981; 157: 191-9.
  4. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010; 85: S3-14.
  5. Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005; 101: 1738-49.
  6. Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 2000; 54: 564-74. https://doi.org/10.1212/WNL.54.3.564
  7. Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 1999; 17: 429-33. https://doi.org/10.1016/S0885-3924(99)00032-9
  8. Tanelian DL, MacIver MB. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 1991; 74: 934-6. https://doi.org/10.1097/00000542-199105000-00020
  9. Chabal C, Russell LC, Burchiel KJ. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 1989; 38: 333-8. https://doi.org/10.1016/0304-3959(89)90220-0
  10. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23: 361-74. https://doi.org/10.1016/0304-3959(85)90006-5
  11. Nagy I, Woolf CJ. Lignocaine selectively reduces C fibreevoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptormediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 1996; 64: 59-70. https://doi.org/10.1016/0304-3959(95)00072-0
  12. Jensen MP. Using pain quality assessment measures for selecting analgesic agents. Clin J Pain 2006; 22: S9-13. https://doi.org/10.1097/01.ajp.0000193829.45571.4f
  13. Carroll IR, Younger JW, Mackey SC. Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain. Pain Med 2010; 11: 617-21. https://doi.org/10.1111/j.1526-4637.2010.00807.x
  14. Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 2005; 6: 98-106. https://doi.org/10.1016/j.jpain.2004.11.002
  15. Tremont-Lukats IW, Hutson PR, Backonja MM. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin J Pain 2006; 22: 266-71. https://doi.org/10.1097/01.ajp.0000169673.57062.40
  16. Ellemann K, Sjögren P, Banning AM, Jensen TS, Smith T, Geertsen P. Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clin J Pain 1989; 5: 291-4. https://doi.org/10.1097/00002508-198912000-00003
  17. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 1996; 82: 91-7.
  18. Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain 2000; 87: 7-17. https://doi.org/10.1016/S0304-3959(00)00229-3

Cited by

  1. Best practices in the treatment of neuropathic pain vol.3, pp.6, 2013, https://doi.org/10.2217/pmt.13.50
  2. efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain vol.20, pp.5, 2015, https://doi.org/10.1002/ejp.794
  3. Systematic review of management of chronic pain after surgery vol.104, pp.10, 2017, https://doi.org/10.1002/bjs.10601
  4. Spine vol.1, pp.3, 2012, https://doi.org/10.1302/2048-0105.13.360045
  5. Effect of intravenous lidocaine infusion on long-term postoperative pain after spinal fusion surgery vol.97, pp.13, 2018, https://doi.org/10.1097/MD.0000000000010229
  6. Lidocaine Infusion: A Promising Therapeutic Approach for Chronic Pain vol.8, pp.1, 2012, https://doi.org/10.4172/2155-6148.1000697
  7. Intra-Venous Lidocaine to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis vol.10, pp.None, 2019, https://doi.org/10.3389/fneur.2019.00954